Eukaryotic cells are organized into a complex system of subcompartments, each with its distinct protein and lipid composition. A continuous fl ux of membranes crosses these compartments, and in some cases direct connections exist between the different organelles. It is thus surprising that they can maintain their individual identities. Small GTPases and the phosphoinositides have emerged as the key regulators in the maintenance of the identity of the Golgi complex. This property is due to their ability to act either alone or, more often, in combination, as cues directing and controlling the recruitment of proteins that possess phosphoinositide-binding domains. Among these many proteins there are the lipid transfer proteins, which can transfer ceramide, oxysterol, cholesterol and possibly glucosylceramide. By regulating these lipid transfer proteins in this way, this binomial combination of the small GTPases and the phosphoinositides acquires a further important role: control of the synthesis and/or distribution of other important integral constituents of cell organelles, such as the sphingolipids and cholesterol. This role is particularly relevant at the level of the Golgi complex, a key organelle in the biosynthesis, transport and sorting of both lipids and proteins that is located at the intersection of the secretory and endocytic pathways.
Introduction
The GC (Golgi complex) represents the central organelle of the secretory pathway, in that it receives and exchanges membranes with the ER (endoplasmic reticulum), the PM (plasma membrane) and the endosomal system. In mammalian cells, the GC is organized as a ribbon that is made up of interconnected stacks of fl at cisternae. The cisternae at the cis side of the GC receive transport intermediates carrying newly synthesized lipids and proteins (cargo) from the ER. The cargo progresses through the Golgi stack in a cis-to-trans direction, and at the TGN (trans-Golgi network) it is specifi cally sorted to different destinations. Recently, it has been shown that the passage of cargo through the stack elicits the formation of intercisternal connections [1] . Despite this continuous fl ux of membranes and of these continuities, the Golgi cisternae maintain their distinct compositions in terms of their lipid and protein content [2] . Indeed, Golgi-resident proteins, such as the Golgi glycosylating enzymes, have a polarized distribution across the stacks. In particular, the enzymes involved in the remodelling of glycoproteins are distributed as a cis-trans gradient according to their site and order of intervention on the sugar chains.
The lipid composition of the different cisternae of the Golgi stacks is also not homogeneous, with the early (cis) Golgi cisternae having a lipid content closer to that of the ER [3] and the TGN having a lipid composition similar to that of the PM and endosomes (which includes an enrichment in cholesterol and the sphingolipids).
The maintenance of the identity of the GC itself and of the different sub-Golgi compartments relies on multiple processes, which include the retention and retrieval of specifi c lipid and protein components, the localized recruitment of cytosolic proteins, and the generation of specifi c lipid species. However, the mechanisms that are ultimately responsible for the maintenance of the compartmentalization in the cell and the polarization of the cisternae have not yet been precisely defi ned, and many factors appear to be involved. Among these, the small GTPase ARF1 (ADP-ribosylation factor-1) and the phosphoinositides have emerged as the key regulators of these processes through their ability to spatially and temporally control the recruitment of different molecular machineries via interactions with protein domains that specifi cally bind the different phosphoinositide species [2] . These machineries appear to directly control elementary steps in membrane traffi cking (such as budding and sorting), to mediate interactions with the cytoskeleton and its related motor proteins, and to control the synthesis and distribution of key lipid species, such as the sphoingolipids and cholesterol, as is seen for the lipid transfer proteins.
ARF1 and the phosphoinositides at the Golgi complex
The small GTPase ARF1 has a central role in maintaining the identity, structure and function of the GC [2] . This role is exemplifi ed by the dismantling of the GC and its redistribution into the ER that is induced by the inactivation of ARF1 by the fungal toxin brefeldin A [4] [5] [6] . Given this important role, it is not surprising that the activity of ARF1 is tightly controlled by a series of factors that regulate its state of activation (i.e. its GTP-bound state) through promotion of the exchange of GDP with GTP [the GEFs (guanine nucleotide exchange factors)], and of the hydrolysis of GTP into GDP [the GAPs (GTPase activating proteins)] [7] . ARF1 exerts its central role in the GC by acting on different effectors, which include, among others, coat and/or adaptor proteins, such as COPI (coatomer protein I), the GGAs [Golgi-associated γ-adaptin ear homology domain Arf (ADP-ribosylation factor)-interacting protein] and AP1 (activating protein 1) [8] , and lipid-modifying enzymes, such as PLD (phospholipase D) [9] and the phosphoinositide kinases (PtdInsKs; both PtdIns4K and PtdInsP5K) [10] . The coat and adaptor proteins control the cargo sorting into transport carriers, the budding of these carriers from the different levels of the stack, and the directed delivery to their different destinations in both anterograde and retrograde directions.
Among the lipid species where their production is under the control of ARF1, the phosphoinositides have been the focus of particular attention over the last few years. Following on from the seminal work of Bob Michell [11] , where the phosphoinositides were originally identifi ed as precursors of important second messengers at the PM, they have now been shown to be important signals themselves, which are generated and act not only at the PM, but also within various intracellular membrane compartments. Indeed, almost every organelle is endowed with its specifi c set of PtdInsKs and PtdInsP phosphatases [12] .
The GC contains many PtdInsKs (including PtdIns3Ks, PtdIns4Ks and PtdInsP5Ks) and PtdInsP phosphatases [including PtdIns 3-phosphatase [13] ; PtdIns 4-phosphatase, and the PtdIns 5-phosphatases OCRL (oculocerebrorenal syndrome of Lowe)-1 and the 75 kDa 5-phosphatase pharbin]. OCRL is of particular relevance, since genetic defects in this protein lead to the development of Lowe syndrome, a rare disease that results in severe impairment of the eyes, the central nervous system and the kidney [14] . The severe consequences induced by the loss of this PtdIns 5-phosphatase that is localized at the GC and the endosomes highlights the importance of the maintenance of the correct balance of the different phosphoinositide species at the level of these compartments [12] .
The most-studied of the PtdInsKs at the GC are the PtdIns4Ks: PtdIns4KIIα and PtdIns4KIIIβ. The latter is recruited to the GC membranes by the GTP-bound form of ARF1 [10] , and it can be activated in vitro by ARF1 [15] . In addition, ARF1 can interact directly with PtdIns4KIIIβ. Furthermore, ARF1 can interact with the NCS (neuronal calcium sensor)-1 Ca 2+ -binding protein that also regulates PtdIns4KIIIβ activity [16] . The interaction between ARF1 and PtdIns4KIIIβ is also conserved in yeast, as synthetic lethality has been reported for the yeast PtdIns4K Pik1p and Arf [17] .
Thus the recruitment and activity of PtdIns4KIIIβ is controlled by the GTPase ARF1. However, PtdIns4KIIIβ can, in turn, act on another GTPase, Rab11, since it has been shown that PtdIns4KIIIβ recruits Rab11 to the GC [18] . Also in this case the interaction will have important functional consequences, since it is conserved in yeast, where the interaction between Pik1p and the yeast homologue of Rab11, Ypt31p, has been shown to be important for protein traffi cking through the secretory pathway [19] . Finally, the kinase activity of PtdIns4KIIIβ is also regulated by PKD (protein kinase D)-mediated phosphorylation [20] . Less is known about the regulation of the other Golgi-associated PtdIns4K, PtdIns4KIIα, although it is ARF-independent and resides and acts in the endosomal compartments [10, 21] .
Therefore the activity of PtdIns4KIIIβ is required to maintain the structure of the GC and to control the traffi cking of cargo through and out of the GC [10, 22] , while PtdIns4KIIα is involved in GC-to-PM and GC-to-endosome traffi cking and also acts at the late endosome level, where it controls the degradation of endocytosed epidermal growth factor [23] .
The product of the activity of the PtdIns4Ks, PtdIns4P, is the substrate of the PtdInsP5K, and thus the precursor of PtdIns(4,5)P 2 . Although the molecular identity of the Golgi-specifi c PtdInsP5K remains to be defi ned, its product, PtdIns(4,5)P 2 , has a role in the maintenance of both the structure and function of the GC: it has been shown to be required to build and maintain the architecture of the GC [24] , for the biogenesis of post-Golgi carriers [24] , and for the transport of apically directed cargo to the PM [25] . For the effectors of PtdIns(4,5)P 2 at the GC, the actin-spectrin skeleton is particularly relevant, considering its role both in the structure and the function of the GC [24, 26, 27] . In addition, PtdIns(4,5)P 2 is an important co-factor for ARF-dependent PLD, and a regulator of the ARF exchange factors [28] .
At the same time, PtdIns4P is not just the precursor of PtdIns(4,5)P 2 . Indeed, following studies originally carried out in yeast, it has become clear in the last few years that PtdIns4P has its own functions and its own effectors, especially at the GC [29] . Among these, there are the OSBPs (oxysterolbinding proteins), the GPBP (Goodpasture antigen-binding protein)/CERT (ceramide transfer protein), and the FAPPs (four-phosphate adaptor proteins): all of these proteins share a PH (pleckstrin homology) domain that preferentially binds to PtdIns4P, while at least OSBP1 and the FAPPs also bind to ARF1. The binding selectivities of these proteins are thus responsible for their targeting to the GC, and in particular to the late Golgi and TGN. Interestingly all of these proteins have also been implicated in and/or suggested to have a role in lipid sensing, transfer and metabolism. In the present chapter, we individually analyse GPBP/CERT, OSBP1 and the FAPPs with respect to their known functions and regulation.
CERT
In their search for a resistance factor to the toxin lisenin (which acts by binding to surface sphingomyelin) in a cell clone (LY-A cells), Hanada and colleagues identifi ed a protein known as the GPBP. GPBP was shown to be the cytosolic factor that is required for the transport of ceramide to the GC, and thus for the synthesis of sphingomyelin; for this reason the GPBP protein was renamed as CERT [30, 31] . CERT is a 598 amino acid protein that is expressed in a full-length form and as an alternatively spliced form that lacks an exon of 78 bp that encodes a 26 amino acid, serine-rich region [32] . CERT has a PH domain at its N-terminus, a FFAT (two phenylalanines [FF] in an acidic tract) motif, and a START [steroidogenic acute regulatory (StAR)-related lipid-transfer] domain at its C-terminus.
The CERT PH domain (CERT-PH) shares a remarkable sequence similarity with the PH domains of OSBP1 and the FAPPs, and retains the property of selectively binding PtdIns4P [33, 34] . CERT-PH is critical for CERT localization and function, as exemplifi ed by the observation that its mutation in Gly 76 is responsible for the lack of function of CERT in the LY-A cell clone that was originally found to be resistant to lisenin. A second GC binding site in CERT-PH has not been formally demonstrated to date; however, its similarity with the OSBP1 and FAPP PH domains (also at the level of the β-7 strand, that has been proposed to drive the PH-domain interaction with ARF1 [35] ) and the restricted localization of CERT-PH to the TGN [36] suggest that similar two-site binding that is mediated by PtdIns4P and ARF will also be involved in its recruitment to the GC.
The FFAT motif is an ER-localization motif: indeed, it is known to target soluble proteins to the ER by virtue of its binding to the type II transmembrane ER proteins VAP-A and VAP-B [37, 38] . The interaction between CERT and the VAPs has also been shown to be modulated and enhanced, in particular, under conditions in which sphingomyelin synthesis is stimulated by the oxysterols [39] .
The C-terminal ceramide binding domain of CERT is known as a START domain, the prototype of which was originally described as a cholesterolbinding motif in the StAR protein [40] [41] [42] [43] . With CERT, its C-terminal START domain has been shown to bind ceramide, and not cholesterol or other phospholipids [44] . An analysis of the intermembrane transfer of ceramide has also demonstrated that the CERT START domain binds and transfers D-erythro-ceramides with different N-acyl-chains, with a preference for C 14 , C 16 , C 18 and C 20 ceramides. Moreover, CERT binds to fl uorescent ceramide analogues with a 1:1 stoichiometry, consistent with a monomeric lipid transport mechanism [44] .
Owing to its ability to transfer ceramide specifi cally from the ER to the late Golgi, where sphingomyelin synthase I is located, CERT acquires a central role in the biosynthesis of sphingomyelin (Figure 1) . Indeed, the identifi cation of a protein like CERT provided an important answer to one of the main questions in the fi eld that stemmed from the observation that the production of sphingomyelin is largely independent of ER-to-Golgi membrane traffi cking. It has, however, also simultaneously stimulated a number of new questions (i) What are the mechanisms that are responsible for the directionality of ceramide transport by CERT from the ER-to-Golgi, rather than in the opposite direction or to other locations? (ii) How is the coordination between membrane traffi cking and sphingomyelin synthesis achieved? (iii) Does CERT have any direct or indirect roles in membrane traffi cking? Future work is needed to answer these questions.
OSBP1
OSBP1 is a member of a gene family that comprises 12 related proteins, known as the ORPs (OSBP-related proteins), and it was originally identifi ed as a high-affi nity cytosolic receptor for the oxysterols [45] .
It is a soluble protein that has been shown to undergo translocation from a cytosolic/vesicular compartment to the GC in CHO (Chinese hamster ovary) cells challenged with exogenous 25-hydroxycholesterol [46] .
Numerous and pleiotropic effects on cholesterol metabolism have been reported upon overexpression of both wild-type and mutant forms of the OSBPs [39, 47] . However, possibly due to the redundancy of the members of this protein family, a coherent picture of the role and mechanism of action of OSBP1 in cholesterol homoeostasis is still missing. Recently, however, an unexpected role of OSBP1 in signalling was reported by Anderson and colleagues [48] , who showed that due to its ability to bind cholesterol and to form a complex with the pERK (extracellular-signal-regulated kinase)-phosphatases, OSBP1 can control the state of ERK phosphorylation in response to changes in cholesterol levels.
The domain organization of OSBP1 closely resembles that of CERT since it contains a PH domain at its N-terminus, a FFAT motif and an oxysterol-binding domain at its C-terminus. The OSBP1 interaction with the GC has been shown to involve its PH domain and to require both PtdIns4P and ARF1 [34] ; it is also important for the effects of OSBP1 on cholesterol homoeostasis [47] . The OSBP1 interaction with the ER is mediated by the binding of its FFAT motif to VAP-A [37, 49] . This ability of OSBP1 to bind to both the GC and the ER, together with the evidence that some of the yeast OSBP homologues, like Osh1 and 2, are localized at the levels of contact sites between the nuclear envelope and the vacuole, and between the ER and the PM respectively [49] , has raised the interesting possibility that OSBP1 acts at the level of the contact sites existing between the smooth ER and the trans-Golgi cisterna in mammals [50] .
Although many questions remain open as to the actual function of OSBP1 as a lipid transfer protein in mammals, and on its mode of action, important hints may now be coming from the recent advances in the study of one of the yeast oxysterol-binding proteins, Osh4/Kes1p. Osh4/Kes1p is one of the seven yeast OSBP homologues that is able to bind the phosphoinositols through a domain that is distinct from that which binds the sterols, although it is devoid of a 'classical' PH domain [51] . Crystallographic analysis has shown that Osh4p/Kes1p has a hydrophobic tunnel that can accommodate sterols (25-OH oxysterol, ergosterol, cholesterol) and that is covered by a fl exible 'lid'. The authors of this study proposed that the conformational change induced by sterol binding promotes the closure of this lid, and allows the transport of the lipid-bound form through the aqueous environment. In contrast, the apo-form of Osh4p/Kes1p exposes potential phospholipid-binding sites that appear to be responsible for its targeting to sterol donor membranes [52] .
In agreement with this model, it has also been shown that Osh4p/Kes1p specifi cally promotes the non-vesicular transfer of cholesterol and ergosterol between membranes in vitro and that this transfer is more effi cient in the presence of the phosphoinositides [53] . Moreover, in vivo, ergosterol transport has been shown to be regulated by OSBP homologues [53, 54] .
Other studies of OSH4/KES1 have also uncovered a functional link between the OSBPs and vesicle biogenesis at the GC. Indeed, OSH4 deletion by-passed the requirement for SEC14 (a phosphatidylinositol/phosphatidylcholine transfer protein) in regulating vesicular transport at the GC, suggesting that Osh4p/Kes1p and Sec14 regulate the secretory function of the GC through acting on the same pathway [51] . Moreover, genome-wide screening has revealed a role for OSH4/KES1 in cell-surface delivery of a reporter cargo [55] .
FAPPs
FAPP1 and FAPP2 were so named after the observation that they specifi cally bind PtdIns4P. The PH domains of the FAPPs have been shown to bind both PtdIns4P and ARF1, and by the virtue of this binding, to drive the localization of the full-length FAPPs to the GC.
Overexpression of the FAPP1 PH domain (FAPP1-PH) inhibits anterograde traffi cking of neosynthesized proteins from the TGN to the PM, while promoting tubulation of the TGN [56] . Also, knockdown of the FAPPs inhibits the transport of neosynthesized cargo from the TGN to the PM in COS7 cells [56] , and of apical-membrane-destined cargo proteins in polarized MDCK (MadinDarby canine kidney) cells [57] . According to recent fi ndings, the effects of a knockdown of the FAPPs on intracellular traffi cking can be ascribed mainly to the function of FAPP2 ( [57] and M. A. De Matteis and G. D'Angelo, unpublished work).
Human FAPP1 (hFAPP1) is a 300 amino acid protein with an N-terminus PH domain and a putative proline-rich motif at its C-terminus, while hFAPP2 has 507 amino acids and is 80% identical with and 90% similar to hFAPP1 at the N-terminus. However, hFAPP2 differs from hFAPP1 at the C-terminus due to its putative GLTP (glycolipid transfer protein) domain [56] . GLTP is a 24 kDa cytosolic protein that selectively accelerates the intermembrane transfer of glycolipids in vitro [58] , and the C-terminal portion of hFAPP2 has 40% sequence identity with human GLTP. Even though the overall similarity between this C-terminal portion of FAPP2 and GLTP is only partial, the residues that have been shown to be important in the glycolipid transfer activity of GLTP are all well conserved in FAPP2 [58] . Thus FAPP2 has in its molecular structure the potential to act as a glucosylceramide transfer protein that will possibly be involved in the biosynthesis of complex glycosphingolipids, of which glucosylceramide is the common precursor. Indeed, the topology of glucosylceramide is unique among the sphingolipids, since it is synthesized on the cytosolic surface of the GC, at a site that could thus be accessible to a cytosolic protein like FAPP2 (Figure 1) . This glucosylceramide is then transported to the later GC compartments, where after fl ipping onto the lumenal side due to activity of a still-unspecifi ed fl ippase, it is converted into lactosylceramide and complex glycosphingolipids. The demonstration that FAPP2 is not just a putative, but is an actual glucosylceramide transfer protein operating in the synthetic pathway of complex glycolipids, remains a challenge for future studies. This would be of particular relevance since the glycosphingolipids, together with sphingomyelin and cholesterol, represent important constituents of the membranes of the late-GC, endosome and PM. 
Conclusion and future directions
Membrane traffi cking and organelle identity are governed by many and multiple intimate relationships between proteins and lipids. The secretory pathway has been widely studied with respect to protein traffi cking and the protein-based traffi cking machineries, while much less is known about the way that the lipids are transported to their fi nal destinations and how they reach and maintain their uneven distributions in the cell. Indeed, the GC behaves as a lipid asymmetry generator, providing the distinction between the pre-Golgi and early-Golgi membranes, which are poor in sphingolipids and cholesterol, and the late-Golgi and post-Golgi membranes, which are enriched in sphingolipids and cholesterol.
The sorting of the different membrane constituents into transport carriers that are destined for different acceptor organelles appears more to depend on than to produce 'lipid asymmetry' [3] . Thus an intriguing hypothesis is that non-vesicular lipid transport contributes signifi cantly to the asymmetric lipid distribution of the cell, and as a consequence, to membrane traffi cking. In this context, great advances were made with the identifi cation of the lipid-transfer proteins CERT and OSBP1, and with the demonstration or implication of their roles in transporting cholesterol (OSBP1) and ceramide (CERT) (Figure 1) .
The great challenges for the future are therefore to reveal the molecular mechanisms by which these lipid-transfer proteins regulate membrane traffi cking, and to provide a more integrated view of how the functions of the different molecular machineries are coordinated at the organelle and cellular levels. What at present remains certain is the pivotal role in this process that the small GTPases and phosphoinositides have, as they are good candidates to drive not only the elementary processes of membrane traffi cking, but also the vectorial non-vesicular transfer of lipids.
